We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

150 hedge funds and large institutions have $334M invested in Akebia Therapeutics in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,023% more call options, than puts

Call options by funds: $19.3M | Put options by funds: $468K

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

1% less funds holding

Funds holding: 151 → 150 (-1)

5% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 21

2.05% less ownership

Funds ownership: 73.76% → 71.7% (-2.1%)

21% less capital invested

Capital invested by funds: $421M → $334M (-$86.5M)

Holders
150
Holders Change
-1
Holders Change %
-0.66%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
44
Reduced
44
Closed
21
Calls
$19.3M
Puts
$468K
Net Calls
+$18.8M
Net Calls Change
-$4.86M

Top Buyers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
+$1.62M
2
BlackRock
BlackRock
New York
+$1.51M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.27M
4
Northern Trust
Northern Trust
Illinois
+$1.21M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.15M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$9.23M
2
Man Group
Man Group
United Kingdom
-$2.44M
3
OWIM
Old West Investment Management
California
-$935K
4
Morgan Stanley
Morgan Stanley
New York
-$809K
5
Bank of America
Bank of America
North Carolina
-$785K
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
151
Weld Capital Management
New York
– -$206K -42,566 Closed
JG
152
Jefferies Group
New York
– -$184K -38,039 Closed
AHC
153
Adell Harriman & Carpenter
Texas
– -$102K -21,037 Closed
ARTA
154
A.R.T. Advisors
New York
– -$84K -17,353 Closed
USAA
155
United Services Automobile Association
Texas
– -$74K -15,341 Closed
OC
156
Oppenheimer & Co
New York
– -$59K -12,100 Closed
MIM
157
Marco Investment Management
Georgia
– -$57K -11,783 Closed
KWM
158
Kingsview Wealth Management
Oregon
– -$53K -10,877 Closed
WS
159
Wedbush Securities
California
– -$52K -10,800 Closed
Canada Life
160
Canada Life
Manitoba, Canada
– -$41K -8,418 Closed
Walleye Trading
161
Walleye Trading
New York
– -$29K -5,910 Closed
NIT
162
NumerixS Investment Technologies
British Columbia, Canada
– -$18K -3,739 Closed
PCM
163
Prelude Capital Management
New York
– -$7K -1,408 Closed
PCP
164
Proficio Capital Partners
Massachusetts
– -$2K -377 Closed
MWC
165
MKD Wealth Coaches
Michigan
– -$2K -365 Closed
RE
166
RBC Europe
United Kingdom
– -$1.72K -355 Closed
QI
167
QS Investors
New York
– -$1K -202 Closed
SIM
168
Sonora Investment Management
Arizona
– -$1K -175 Closed
3 4 5 6
7

AKBA Hedge Fund Activity: Q3 2019 in Review

150 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q3 2019, worth a combined $334M — down 21% from $421M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of AKBA and 20 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 44 added.

The largest buyer was Sofinnova Investments, adding an estimated $1.62M. The largest seller was State Street, cutting an estimated $9.23M.

  • 150 institutional investors held Akebia Therapeutics (AKBA) as of Q3 2019, down from 151 in Q2 2019.
  • Funds reported $334M of Akebia Therapeutics stock for Q3 2019, down 21% quarter-over-quarter.
  • 20 funds opened new Akebia Therapeutics positions in Q3 2019 and 21 closed out, a net change of -1 holder.
  • The largest Akebia Therapeutics buyer in Q3 2019 was Sofinnova Investments, an estimated $1.62M added.
  • The largest Akebia Therapeutics seller in Q3 2019 was State Street, an estimated $9.23M sold.

Based on aggregated 13F filings for Q3 2019.